Infinimmune appoints Srikanth Pendyala as new chief medical officer

Infinimmune announced the addition of Srikanth Pendyala to its leadership team as chief medical officer. Pendyala comes to the role after serving in the same capacity at Stealth NewCo and Endeavor Biosciences.

The hire is part of a broader trend of personnel moves within the pharmaceutical sector, which the column tracks weekly. The company highlighted his experience in medical strategy and drug development.

Industry observers note that bringing a seasoned CMO could strengthen Infinimmune’s pipeline and regulatory efforts. No other changes were reported in the article.